Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/47481
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bansback, N. | - |
dc.contributor.author | Ward, S. | - |
dc.contributor.author | Karnon, J. | - |
dc.date.issued | 2004 | - |
dc.identifier.citation | European Journal of Health Economics, 2004; 5(2):188-189 | - |
dc.identifier.issn | 1618-7598 | - |
dc.identifier.issn | 1618-7601 | - |
dc.identifier.uri | http://hdl.handle.net/2440/47481 | - |
dc.description | The original publication can be found at www.springerlink.com | - |
dc.description.statementofresponsibility | Nick Bansback, Sue Ward and Jon Karnon | - |
dc.language.iso | en | - |
dc.publisher | Springer | - |
dc.source.uri | http://springerlink.metapress.com/content/3m7uurmtclxf60n5/ | - |
dc.subject | Gemcitabine | - |
dc.subject | Economic evaluation | - |
dc.subject | Expected value of information | - |
dc.title | “Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK”: How important is quality of life? | - |
dc.type | Journal article | - |
dc.provenance | Published online: 27 February 2004 | - |
dc.identifier.doi | 10.1007/s10198-004-0226-5 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Karnon, J. [0000-0003-3220-2099] | - |
Appears in Collections: | Aurora harvest Public Health publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.